TGFBI and colorectal carcinoma: Recent research highlights five potential biomarkers—INHBA, MMP7, PSAT1, SLC7A5, and TGFBI—with elevated levels in colorectal cancer tissues and serum of patients, showing promise for non‐invasive CRC detection.